Shockwave Medical, Inc.【SWAV】Cash flow
Market cap
P/E ratio
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Depreciation & amortization | - | - | - | 5 | 10 |
| Stock-based compensation | 4 | 10 | 27 | 45 | 73 |
| Cash from operations | -48 | -71 | 15 | 118 | 196 |
| Capital expenditures | -4 | -12 | -12 | -25 | -31 |
| Cash from investing | -60 | -107 | 26 | -62 | -626 |
| Proceeds from issuance of term debt, net | - | 3 | - | 24 | - |
| Repayments of term debt | - | - | - | 18 | 105 |
| Cash from financing | 208 | 90 | -2 | 13 | 600 |
| Free cash flow | |||||
| FCF margin (%) |